Literature DB >> 20231833

EGFR (trans)activation mediates IL-8 and distinct human antimicrobial peptide and protein production following skin injury.

Amanda S Büchau1.   

Abstract

Antimicrobial peptides and proteins (AMPs) are tools of the innate immune system employed at injury sites to protect the host from invading microbes and to promote wound repair. In this issue, Roupé et al. characterize epidermal innate immune responses induced by skin injury and the involvement of EGFR for distinct AMPs and IL-8 induction.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20231833     DOI: 10.1038/jid.2009.371

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  5 in total

1.  A role for aberrantly expressed nuclear localized decorin in migration and invasion of dysplastic and malignant oral epithelial cells.

Authors:  Nyla Dil; Abhijit G Banerjee
Journal:  Head Neck Oncol       Date:  2011-09-29

Review 2.  The Innate Immune System in Acute and Chronic Wounds.

Authors:  Amanda S MacLeod; Jonathan N Mansbridge
Journal:  Adv Wound Care (New Rochelle)       Date:  2016-02-01       Impact factor: 4.730

3.  Epidermal Growth Factor Receptor Signaling Enhances the Proinflammatory Effects of Staphylococcus aureus Gamma-Toxin on the Mucosa.

Authors:  Aaron N Gillman; Laura M Breshears; Charles K Kistler; Patrick M Finnegan; Victor J Torres; Patrick M Schlievert; Marnie L Peterson
Journal:  Toxins (Basel)       Date:  2017-06-28       Impact factor: 4.546

Review 4.  Skin Immunity to Dermatophytes: From Experimental Infection Models to Human Disease.

Authors:  Verónica L Burstein; Ignacio Beccacece; Lorena Guasconi; Cristian J Mena; Laura Cervi; Laura S Chiapello
Journal:  Front Immunol       Date:  2020-12-02       Impact factor: 7.561

5.  Activation of Molecular Signatures for Antimicrobial and Innate Defense Responses in Skin with Transglutaminase 1 Deficiency.

Authors:  Takashi Haneda; Yasutomo Imai; Ryosuke Uchiyama; Orie Jitsukawa; Kiyofumi Yamanishi
Journal:  PLoS One       Date:  2016-07-21       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.